• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER WITH BLOOD CONTROL; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER WITH BLOOD CONTROL; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382523
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/23/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the iv cannula of the bd insyte autoguard bc shielded iv catheter with blood control split during insertion.There was no report of exposure, injury, or medical intervention noted.
 
Event Description
It was reported that the iv cannula of the bd insyte¿ autoguard¿ bc shielded iv catheter with blood control split during insertion.There was no report of exposure, injury, or medical intervention noted.
 
Manufacturer Narrative
Correction: due to an it issue beginning on 7/3/2018, previously filed emdrs did not contain required fields.This supplemental emdr is filed to provide the following omitted fields: sex: female.Event attributed to: other.Device single use?: no.Device returned to manufacture: no.Investigation summary: a complaint history check was performed and this is the 2nd related complaint reported with the defect/condition of catheter defective / damaged with lot #6343529 regarding item #382523.Dhr review; was conducted for this investigation which disclosed the following: lot 6343529; was built and packaged on afa line 11 from 12dec2016 through 22dec2016 for the quantity of (b)(4).All challenge, set-up and in process samples were performed in accordance to the quality control plan and all passed per specifications.Dhr review disclosed no indication of the defect as it was noted that there were no ip quality notifications initiated during production of this lot that would impact upon the quality of the product.There was one temporary deviation (td 2016-78) in affect during the build of this lot.Sap (qn) database review; was conducted for this investigation, which disclosed the following: there were no reject activity findings relevant to the defect associated with the lot number provided for this incident.No qns were initiated for this lot.Two photos were provided for this incident which revealed a 22g bd insyte autoguard unit which was out of packaging and used.The unit consisted of the catheter/adapter assembly and the needle/hub assembly with grip and barrel.There was also a top web (tyvek/label) from a 22 ga bd insyte autoguard from lot 6343529.Photos revealed the needle was piercing through the tubing wall near the nose of the adapter; indicative of a base spear thru.There were traces of thick media present within the catheter tubing wall and in the flashback chamber of the needle assembly.The media present within the catheter tubing and flashback chamber was evidence that the catheter and needle were intact at time of puncture/insertion.Therefore there was no physical evidence that the failure was manufacturing process related.Analysis of peura (end user risk analysis) disclosed that due to low occurrence and limited severity, current risk is acceptable.A formal corrective action will not be initiated at this time.Customer complaint trends are evaluated on a monthly basis.If the trend of a specific type of complaint warrants a formal corrective action, resources will be assigned at that time.Product quality is evaluated during the manufacturing process with prescribed variable and attributes inspections.These inspections are performed by operators and/or process control technicians to ensure any gross process changes are identified.If defects are observed, disposition of the product, root cause and corrective action are applied according to the quality control plan.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER WITH BLOOD CONTROL
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7778138
MDR Text Key117017921
Report Number1710034-2018-00537
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903825234
UDI-Public30382903825234
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 09/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/30/2019
Device Catalogue Number382523
Device Lot Number6343529
Was Device Available for Evaluation? No
Date Manufacturer Received07/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-